NCT00242190View on ClinicalTrials.gov

Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

February 28, 2010

Conditions

Pancreatic Neoplasms

Interventions

DRUG

oxaliplatin

DRUG

gemcitabine

PROCEDURE

radiation therapy

Trial Locations (1)

48109

University of Michigan, Ann Arbor

Sponsors

Collaborators (1)

Sanofi-Synthelabo

All Listed Sponsors

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

University of Michigan Rogel Cancer Center

OTHER